Why are some MEN1 lesions almost always benign (e.g., MEN 1 parathyroid tumors), whereas homozygous MEN1 inactivation is frequently found in malignant tumors of the endocrine pancreas? This evidence concerns the gene MEN1 and pancreatic neuroendocrine neoplasm.